<ѻýҕl>Could Docetaxel Have Role in Unfavorable-Risk Prostate Cancer?ѻýҕl> Use of chemo reduced radiation-induced cancers, and may prolong OS in low-PSA subgroup Jul 07, 2021
<ѻýҕl>Tweaking Maintenance Options in Metastatic CRCѻýҕl> Two studies move the needle, but no major breakthroughs Jun 11, 2021
<ѻýҕl>Perioperative Chemo Enough in Esophageal Cancer?ѻýҕl> MAGIC/FLOT regimens yielded similar overall survival to multimodal CROSS regimen Jun 06, 2021
<ѻýҕl>Adding Chemo to Standard Care No Help for Cervical Cancerѻýҕl> Similar OS, PFS, and patterns of recurrence, with more toxicity Jun 04, 2021
<ѻýҕl>PD-L1 Inhibitor Thwarts Recurrence in Early Lung Cancerѻýҕl> Risk of death, recurrence 34% lower with atezolizumab after surgery and chemo May 19, 2021
<ѻýҕl>What's Behind the Mysterious Chest Pain in Bladder Cancer Patient?ѻýҕl> Cardiomyopathy risks interrupting cancer treatment, worsening prognosis May 03, 2021
<ѻýҕl>New Clues to Sleep Problems, Solutions in Cancer Patientsѻýҕl> Studies in GI and breast cancers zero in on sleep disturbance during active treatment Apr 30, 2021
<ѻýҕl>What to Do With a Rare, Aggressive Bladder Cancerѻýҕl> Case authors lament scant information on treatments or outcomes Apr 26, 2021
<ѻýҕl>Chemotherapy Nausea Linked to Stress, Neuropsych Symptomsѻýҕl> High frequency of CIN leads to stress and more severe neuropsychological symptoms Apr 23, 2021
<ѻýҕl>Auricular Acupressure May Relieve Neuropathy in Breast Cancerѻýҕl> First randomized trial of the noninvasive technique in such patients Apr 22, 2021
<ѻýҕl>More Benefit With Taxane for Aggressive Metastatic Prostate Cancerѻýҕl> Higher clinical benefit rate with front-line cabazitaxel versus androgen receptor inhibitor Apr 12, 2021
<ѻýҕl>Triple-Negative Breast Cancers Not All the Sameѻýҕl> Histology tied to treatment response, outcomes Apr 12, 2021
<ѻýҕl>Anti-PD-L1 Flops in Locally Advanced Head and Neck Cancerѻýҕl> No PFS benefit from adding avelumab to chemoradiation, hazard ratio favored placebo Apr 02, 2021
<ѻýҕl>HIPEC Combo Doubles PFS in Advanced Ovarian Cancerѻýҕl> Cisplatin/paclitaxel boosts outcomes without increasing complications in registry study Mar 26, 2021
<ѻýҕl>Little Benefit With Adjuvant Therapy for High-Risk Endometrial Cancerѻýҕl> Chemo prevented relapse but did not improve survival, no benefit from radiotherapy Mar 23, 2021
<ѻýҕl>Practice-Changing Trial in Second-Line Endometrial Cancerѻýҕl> Pembrolizumab plus lenvatinib improved median OS by nearly 7 months versus chemotherapy Mar 19, 2021
<ѻýҕl>New Drug OK'd for Chemo-Induced Myelosuppression in SCLCѻýҕl> CDK4/6 inhibitor cut the risk for severe neutropenia in small-cell lung cancer patients Feb 13, 2021
<ѻýҕl>Survival Boost in Bladder Cancer With Antibody-Drug Conjugateѻýҕl> Four-month absolute improvement with enfortumab vedotin in previously treated disease Feb 12, 2021
<ѻýҕl>Anti-CD20 Drugs Tied to Severe COVID in Cancer Patientsѻýҕl> Plus: Active chemo treatment may not be a COVID risk factor Feb 05, 2021
<ѻýҕl>Optimizing Neoadjuvant Therapy for Breast Cancerѻýҕl> ASCO guideline covers patient selection, treatment options, follow-up Feb 02, 2021
<ѻýҕl>Dustin Diamond's Small Cell Lung Cancerѻýҕl> "Saved by the Bell" actor diagnosed after exhaustive testing Feb 02, 2021
<ѻýҕl>KRAS Inhibitor Continues to Impress in NSCLCѻýҕl> Sotorasib yielded deep and durable responses in over one-third of patients Feb 01, 2021
<ѻýҕl>Nab-Paclitaxel as Possible Option for Relapsed NSCLCѻýҕl> Noninferior to docetaxel for OS, though impact on clinical practice questioned Feb 01, 2021
<ѻýҕl>Should COVID-Strained Centers Hit Pause on Lung Cancer Screening?ѻýҕl> A debate on what stopping scans would do to health systems, patients Feb 01, 2021
<ѻýҕl>Montana Oncologist Fired for Misdiagnosing, Overtreating Patientsѻýҕl> But some rally around him Jan 26, 2021
<ѻýҕl>Preop RT Flunks Test in Borderline Pancreatic Cancerѻýҕl> Chemotherapy alone judged efficacious but not chemoradiation Jan 20, 2021
<ѻýҕl>Copay Assistance Programs Help Patients but Confuse Them Tooѻýҕl> Insurers keep track of their use and in some cases won't apply them to patient deductibles Jan 13, 2021
<ѻýҕl>Medicare's 'Most Favored Nation' Drug-Pricing Rule in Limboѻýҕl> Rule affecting Part B drugs was to take effect Jan. 1 but was stopped by federal court orders Jan 07, 2021
<ѻýҕl>Adjuvant Palbociclib Fails in Early, High-Risk Breast Cancerѻýҕl> No iDFS benefit with 1 year of CDK4/6 inhibition following neoadjuvant chemotherapy Dec 10, 2020
<ѻýҕl>Chemo-Free Combo Boosts PFS in First-Line CLLѻýҕl> PI3K-delta-based regimen also topped chemoimmunotherapy in relapsed setting Dec 08, 2020
<ѻýҕl>Chemotherapy Improved TNBC Survival in Older Womenѻýҕl> Benefits noted in both node-negative and -positive disease, as well as for those with a comorbidity score greater than 0 Dec 08, 2020
<ѻýҕl>Three-Drug Regimen Reduces Myeloma Treatment Burdenѻýҕl> Efficacy maintained with addition of SQ daratumumab to pomalidomide, dexamethasone Dec 04, 2020
<ѻýҕl>Anal Cancer on the Rise in U.S., Especially in Womenѻýҕl> Whites also had a higher risk than Blacks for HPV-linked disease Oct 26, 2020
<ѻýҕl>CDK4/6 Inhibitor in SCLC Cuts Chemo-Induced Myelosuppressionѻýҕl> Reduced severe neutropenia and less need for supportive care with trilaciclib Oct 20, 2020
<ѻýҕl>Dual Checkpoint Blockade With Some Chemo Boosts OS in NSCLCѻýҕl> Nivolumab-ipilimumab with two cycles of chemotherapy improved survival, regardless of histology or PD-L1 status Oct 17, 2020
<ѻýҕl>Positive Anti-PD-1 Data in Gastric, Esophageal Cancerѻýҕl> Better OS, PFS with nivolumab, pembrolizumab in advanced/metastatic disease Sep 23, 2020
<ѻýҕl>Immunotherapy Falls Short Again in Ovarian Cancerѻýҕl> No PFS benefit in advanced disease with addition of atezolizumab to chemo, bevacizumab Sep 23, 2020
<ѻýҕl>No Luck for Chemo-Free Tx in First-Line Bladder Cancerѻýҕl> Durvalumab alone or with tremelimumab no better than chemotherapy Sep 22, 2020
<ѻýҕl>No Benefit With Anti-PD-L1 Drug in Metastatic TNBCѻýҕl> Lack of progression-free, overall survival boost with atezolizumab contrast with prior trial Sep 22, 2020
<ѻýҕl>Skip Chemo for Older Patients With HER2+ Breast Cancer?ѻýҕl> Less than one-month survival loss at 3 years with trastuzumab monotherapy Sep 18, 2020